Position
Squarepoint Ops LLC in Emergent BioSolutions Inc.
Back to the book · All holders of EBS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$723.9K$12.36 → $8.30
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 178.3K | $2.2M | — | — | — | 0.0% |
| Q1 2026 | 299.4K | $2.49M | $8.30 | −$723.9K | $1.01M | 0.0% |